Allegati: Rep. 288_22 - Viiv Healthcare srl.pdf (751.52 KB)Rep. 293_22 - MYLAN ITALIA SRL(12 MESI).pdf (752.41 KB)Rep. 318 - ROCHE SPA.pdf (754.02 KB)Rep. 334_22 - NEURAXPHARM ITALY SPA(36 mesi).pdf (758.89 KB)Rep. 291_22 - MYLAN ITALIA SRL (36 MESI).pdf (760.25 KB)Rep. 292_22 - MYLAN ITALIA SRL(24 MESI).pdf (753.29 KB)Rep. 300_22 - MONICO SPA.pdf (754.14 KB)Rep. 301_22 - ORION PHARMA SRL.pdf (757.44 KB)Rep. 302_22 - SANOFI SRL.pdf (416.38 KB)Rep. 303_22 - teofarma srl (24 mesi).pdf (758.44 KB)Rep. 304_22 - teofarma srl(36 mesi).pdf (750.68 KB)Rep. 305_22 - TEVA ITALIA SRL.pdf (754.19 KB)Rep. 306_22- Accord Healthcare Italia srl.pdf (741.23 KB)Rep. 307_22-Alnylam Italy srl.pdf (744.65 KB)Rep. 308_22-CSL Behring SpA.pdf (738.4 KB)Rep. 309_22-Dompè Farmaceutici SpA.pdf (487.65 KB)Rep. 310_22- Dr Reddy's srl.pdf (737.18 KB)Rep. 312_22-Eg SpA.pdf (736.86 KB)Rep. 313_22- GlaxoSmithkline SpA.pdf (751.2 KB)Rep. 314_22 - Theramex Italy srl.pdf (753.17 KB)Rep. 315_22-Eli Lilly SpA.pdf (743.22 KB)Rep. 322_22 - NORDIC Pharma srl.pdf (750.82 KB)Rep. 324_22 - VERTEX Pharmaceuticals srl.pdf (785.91 KB)Rep. 326_22 - SINTESY Pharma srl.pdf (756.79 KB)Rep. 327_22 - TAKEDA Italia spa.pdf (756.47 KB)Rep. 328_22-Alfa Sigma SpA.pdf (738.55 KB)Rep. 329_22-Ethypharm Italy srl.pdf (743.78 KB)Rep. 330_22-Euromed srl (24 mesi).pdf (742.98 KB)Rep. 331_22-Euromed srl (36 mesi).pdf (738.66 KB)Rep. 332_22-FAR.G.IM_. SRL.pdf (735.85 KB)Rep. 333_22-Galapagos Biopharma Italy srl.pdf (744.49 KB)Rep. 335_22 - Neuraxpharm Italy SpA (24mesi).pdf (757.93 KB)Rep. 336_22 - Novo Nordisk spa(24 mesi).pdf (771.31 KB)Rep. 337_22 - Novo Nordisk spa (36 mesi).pdf (772.44 KB)Rep. 338_22 - Sciensus International BV.pdf (756.61 KB)Rep. 339_22-AbbVie srl (36 mesi).pdf (741.14 KB)Rep. 340_22-AbbVie srl(24 mesi).pdf (741.17 KB)Rep. 341_22-AstraZeneca SpA.pdf (387.65 KB)Rep. 342_22-AstraZeneca SpA (24mesi).pdf (739.06 KB)Rep. 343_22 - NORGINE italia srl.pdf (758.67 KB)Rep. 344_22- Chiesi Italia SpA.pdf (745.21 KB)Rep. 345_22 - SVAS biosana spa.pdf (752.15 KB)Rep. 346_22-Eusa Pharma (Italy)srl.pdf (738.43 KB)Rep. 347_22-Ever Pharma Italia srl.pdf (737.44 KB)Rep. 348_22- Fresenius Kabi italia srl (36 mesi).pdf (747.68 KB)Rep. 349_22- Fresenius Kabi italia srl (24 mesi).pdf (739.18 KB)Rep. 350_22- B Braun Italia Spa.pdf (738.95 KB)Rep. 351_22- Leo Pharma Spa.pdf (758.49 KB)Rep. 352_22- Merck Serono Spa.pdf (750.12 KB)Rep. 353_22- Amgen srl.pdf (737.4 KB)Rep. 354_22- Istituto Biochimico Italiano Giovanni Lorenzini SpA.pdf (665.27 KB)Rep. 355_22- Hikma Italia SpA.pdf (748.71 KB)Rep. 356_22 - PHARMAIDEA srl.pdf (669.77 KB)Rep. 359_22 - ZENTIVA ITALIA SRL.pdf (678.33 KB)Rep. 360_22 - PFIZER srl (36 mesi).pdf (687.02 KB)Rep. 361_22 - PFIZER srl (12 mesi).pdf (677.89 KB)Rep. 362_22- Bioproject Italia srl (24 mesi).pdf (670.61 KB)Rep. 363_22- Bioproject Italia srl (36 mesi).pdf (671.96 KB)Rep. 364_22 - SANDOZ srl.pdf (407.14 KB)Rep. 367_22 - MUNDIPHARMA Pharmaceuticals srl.pdf (406.21 KB)Rep. 368_22 - NOVARTIS FARMA spa (36 mesi).pdf (402.64 KB)Rep. 369_22 - NOVARTIS FARMA spa(24 mesi).pdf (402.12 KB)Rep. 370_22 - SHARPER srl.pdf (403.52 KB)Rep. 371_22-Janssen Cilag SpA.pdf (379.96 KB)
